De Luca, G.; Verburg, A.; Hof, A.v.; ten Berg, J.; Kereiakes, D.J.; Coller, B.S.; Gibson, C.M.
Current and Future Roles of Glycoprotein IIb–IIIa Inhibitors in Primary Angioplasty for ST-Segment Elevation Myocardial Infarction. Biomedicines 2024, 12, 2023.
https://doi.org/10.3390/biomedicines12092023
AMA Style
De Luca G, Verburg A, Hof Av, ten Berg J, Kereiakes DJ, Coller BS, Gibson CM.
Current and Future Roles of Glycoprotein IIb–IIIa Inhibitors in Primary Angioplasty for ST-Segment Elevation Myocardial Infarction. Biomedicines. 2024; 12(9):2023.
https://doi.org/10.3390/biomedicines12092023
Chicago/Turabian Style
De Luca, Giuseppe, Ashley Verburg, Arnoud van’t Hof, Jurrien ten Berg, Dean J. Kereiakes, Barry S. Coller, and Charles Michael Gibson.
2024. "Current and Future Roles of Glycoprotein IIb–IIIa Inhibitors in Primary Angioplasty for ST-Segment Elevation Myocardial Infarction" Biomedicines 12, no. 9: 2023.
https://doi.org/10.3390/biomedicines12092023
APA Style
De Luca, G., Verburg, A., Hof, A. v., ten Berg, J., Kereiakes, D. J., Coller, B. S., & Gibson, C. M.
(2024). Current and Future Roles of Glycoprotein IIb–IIIa Inhibitors in Primary Angioplasty for ST-Segment Elevation Myocardial Infarction. Biomedicines, 12(9), 2023.
https://doi.org/10.3390/biomedicines12092023
